Get started
Madrigal Pharmaceuticals, Inc.Madrigal Pharmaceuticals, Inc.Madrigal Pharmaceuticals, Inc.

Madrigal Pharmaceuticals, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Technicals Forecast

MDGL chart

Key stats

Market capitalization
‪4.86 B‬USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−19.94USD
Net income
‪−373.63 M‬USD
Revenue
—
Shares float
‪17.08 M‬
Beta (1Y)
1.89

About Madrigal Pharmaceuticals, Inc.

Sector
Health Technology
CEO
William J. Sibold
Headquarters
West Conshohocken
Website
madrigalpharma.com
Employees (FY)
376
Founded
2011
ISIN
US5588681057
FIGI
BBG000QS6NV8
Madrigal Pharmaceuticals, Inc. engages on the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. The company was founded by Rebecca Taub and Edward Chiang on September 2011 and is headquartered in Fort Washington, PA.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of MDGL is 226.01 USD — it has decreased by 2.32% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Madrigal Pharmaceuticals, Inc. stocks are traded under the ticker MDGL.
Madrigal Pharmaceuticals, Inc. is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Madrigal Pharmaceuticals, Inc. has a max estimate of 565.00 USD and a min estimate of 270.00 USD.
MDGL earnings for the last quarter are −5.34 USD whereas the estimation was −4.90 USD which accounts for −9.08% surprise. Estimated earnings for the next quarter are −5.24 USD. See more details about Madrigal Pharmaceuticals, Inc. earnings.
Yes, you can track Madrigal Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, MDGL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Madrigal Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
MDGL reached its all-time high on Jan 29, 2013 with the price of 415.38 USD, and its all-time low was 5.24 USD and was reached on Feb 8, 2016.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has 376.00 employees. See our rating of the largest employees — is Madrigal Pharmaceuticals, Inc. on this list?